Clinical Efficacy of Non-exfoliating Lux1540nm dot Matrix Laser Combined with Hydroquinone Cream in the Treatment of Chloasma
This paper investigates the clinical efficacy and recurrence rate of non-exfoliating Lux1540nm dot matrix laser combined with hydroquinone cream in the treatment of chloasma. The control group was treated with hydroquinone cream, and the observation group was treated with non-exfoliative lattice laser and hydroquinone cream. The efficacy of the two groups of patients was observed 4 months after the end of treatment, followed by 1 year of follow-up, and the recurrence of the two groups was recorded and recorded. There was no significant difference in baseline data between the two groups (P>0.05). The total effective rate (100%) of the observation group was significantly better than that of the control group (79.41%). The difference between the two groups was statistically significant (P<0.05). Within one year of follow-up, the recurrence rate of the observation group (7.5%) was significantly lower than that of the control group (26.47%). The difference between the two groups was statistically significant (P<0.05). The non-exfoliating Lux1540nm dot matrix laser combined with hydroquinone cream has a significant effect on the treatment of chloasma, with low recurrence rate and high patient compliance.